BofA analyst Jean Ann Salisbury lowered the firm’s price target on Delek US (DK) to $14 from $15 and keeps an Underperform rating on the shares. While Trump decisions could move the needle for specific stocks, the firm reiterates cautious stances on both oil macro and refining valuations, calling the “key stories” the next OPEC decision and how refined product demand tracks through the year after a “very weak” 2024.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US Holdings Expands Midstream with Key Acquisitions
- Wolfe upgrades Delek US to Peer Perform, says value based on Logistics stake
- Delek US upgraded to Peer Perform from Underperform at Wolfe Research
- Delek US price target lowered to $19 from $21 at Morgan Stanley
- Delek US price target lowered to $25 from $26 at Mizuho